Dan Dearborn - 12 Nov 2024 Form 4 Insider Report for TuHURA Biosciences, Inc./NV (HURA)

Role
Chief Financial Officer
Signature
/s/ Dan Dearborn
Issuer symbol
HURA
Transactions as of
12 Nov 2024
Net transactions value
$0
Form type
4
Filing time
14 Nov 2024, 16:46:15 UTC
Previous filing
22 Oct 2024
Next filing
17 Dec 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HURA Options (Right to Buy) Award $0 +489,848 $0.000000 489,848 12 Nov 2024 Common Stock 489,848 $4.94 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-third of the stock options become exercisable on the first, second, and third anniversary of November 12, 2024.